Nepafenac
RxNorm 298665
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 298665 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: nepafenac.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
INPrescribable
Ingredient (IN):
Nepafenac
(Atom ID: 2304785)
PTPrescribable
Designated preferred name (PT):
Nepafenac
(Atom ID: 2384822)
FNPrescribable
Full form of descriptor (FN):
Nepafenac (substance)
(Atom ID: 2384825)
PTPrescribable
Designated preferred name (PT):
Nepafenac-containing product
(Atom ID: 10807828)
FNPrescribable
Full form of descriptor (FN):
Product containing nepafenac (medicinal product)
(Atom ID: 9724990)
Patient Education
Nepafenac Ophthalmic
Ophthalmic nepafenac is used to treat eye pain, redness, and swelling in patients who are recovering from cataract surgery (procedure to treat clouding of the lens in the eye). Nepafenac is in a class of medications called nonsteroidal anti-inflammatory drugs (NSAIDs). It works by stopping the production of certain natural substances that cause pain and swelling.
[Learn More]
* Please review the disclaimer below.